Hepatocellular carcinoma
Conditions
Interventions
integrative treatment group:Nil
Western medicine treatment group:Nil
Sponsors
the Fifth Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the guidelines for primary diagnosis and treatment (BCLC A, B, C); 2. Patients aged 18-80 years; 3. Patients combined with western medicine treatment; 4. The follow-up time is not less than 2 years.
Exclusion criteria
Exclusion criteria: 1. Patients with HCC bleeding; 2. Patients with severe acute or chronic diseases (including myocardial infarction, acute liver failure, renal failure, etc.); 3. Pregnant women or lactating women; 4. Patients with a history of drug abuse or mental disorders; 5. Patients with portal vein invasion or vascular invasion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival;safety; | — |
Countries
China
Contacts
Public ContactWang Ruilin
the Fifth Medical Center of Chinese PLA General Hospital
Outcome results
None listed